Global radiology oncology surgical robot device market poised to reach USD7.3bn by 2022
As per a research report published by Radiant Insights, the global market for radiology oncology surgical robots is projected to reach USD 7.3 billion by 2022. The market reported revenue of USD 4 billion in 2015. Radiology oncology surgical robots use mechanical mobility and continuous image guidance to remove tumors during surgical procedures. The Accuray CyberKnife robotic system is a prominent example of such devices. The factors driving the market growth worldwide include aging populations and comfort and convenience provided by the new technology. The number of new cancer cases diagnosed annually is expected to increase from 14.9 million in 2015 to 20 million by 2025. International markets are not well-equipped to tackle the growing cancer cases. Developing countries would need 9,000 additional treatment machines by 2020. China, India, and Brazil are estimated to require over 3,800, 1,200, and 400 additional machines, respectively. Demands in emerging markets, coupled with ever increasing incidences of cancer, represent additional factors to drive continued growth. Varian, Elekta, and Accuray provide the ultimate robotic solutions to meet medical needs.